Neuropsychiatric Risks of Severe COVID-19, Other Severe Acute Respiratory Infections

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MAY 11, 2022

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.1067?guestAccessKey=0bd25166-1940-4853-b5de-46ab2d856467&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051122

  

About The Study: In this study of more than 8 million adults in England during the COVID-19 pandemic, risks of new anxiety disorder, dementia, psychotic disorder and bipolar disorder diagnoses were significantly increased in adults surviving hospitalization for COVID-19 or other severe acute respiratory infections compared with the general population. Risks of these neuropsychiatric illnesses were similar for COVID-19 and non-COVID severe respiratory infections.

Authors: Peter Watkinson, M.D., of the University of Oxford in Oxford England, is the corresponding author.

 

(10.1001/jamapsychiatry.2022.1067)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.